KAHRAMAN, R. Et Al. 2018. Assessment of the role of EGF +61A/G and EGFR R497K polymorphism in patients with inflammatory bowel disease: A case-control study. Archives of Clinical and Experimental Medicine , vol.3, no.2 , 79-83.

KAHRAMAN, R., İPLİK, E. S., CALHAN, T., ŞAHİN, A., & ÇAKMAKOĞLU, B., (2018). Assessment of the role of EGF +61A/G and EGFR R497K polymorphism in patients with inflammatory bowel disease: A case-control study. Archives of Clinical and Experimental Medicine , vol.3, no.2, 79-83.

KAHRAMAN, Resul Et Al. "Assessment of the role of EGF +61A/G and EGFR R497K polymorphism in patients with inflammatory bowel disease: A case-control study," Archives of Clinical and Experimental Medicine , vol.3, no.2, 79-83, 2018

KAHRAMAN, Resul Et Al. "Assessment of the role of EGF +61A/G and EGFR R497K polymorphism in patients with inflammatory bowel disease: A case-control study." Archives of Clinical and Experimental Medicine , vol.3, no.2, pp.79-83, 2018

KAHRAMAN, R. Et Al. (2018) . "Assessment of the role of EGF +61A/G and EGFR R497K polymorphism in patients with inflammatory bowel disease: A case-control study." Archives of Clinical and Experimental Medicine , vol.3, no.2, pp.79-83.

@article{article, author={Resul KAHRAMAN Et Al. }, title={Assessment of the role of EGF +61A/G and EGFR R497K polymorphism in patients with inflammatory bowel disease: A case-control study}, journal={Archives of Clinical and Experimental Medicine}, year=2018, pages={79-83} }